Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference48 articles.
1. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease;Levey;Am J Kidney Dis,1998
2. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey;Coresh;Am J Kidney Dis,2003
3. Reduced kidney function and anemia as risk factors for mortality inpatients with left ventricular dysfunction;Al-Ahmad;J Am Coll Cardiol,2001
4. Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction;Langston;Kidney Int,2003
5. Impact of renal failure on the risk of myocardial infarction and death;Beddhu;Kidney Int,2002
Cited by 165 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Physician and Patient Preferences for Treatment of Anemia Associated with Chronic Kidney Disease in Japan: A Survey Including Best-Worst Scaling;Patient Preference and Adherence;2024-07
2. Association of Hematological Biomarkers of Inflammation with 10-Year Major Adverse Cardiovascular Events and All-Cause Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: The ARIC Study;Journal of Inflammation Research;2024-07
3. Chest Symptoms and Long-Term Risk of Incident Cardiovascular Disease;The American Journal of Medicine;2024-07
4. Tissue Iron Distribution in Anemic Patients with End-Stage Kidney Disease: Results of a Pilot Study;Journal of Clinical Medicine;2024-06-14
5. Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis;Kidney Research and Clinical Practice;2024-05-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3